Efficacy of calcitonin gene-related peptide (CGRP) receptor blockers in reducing the number of monthly migraine headache days (MHDs): A network meta-analysis of randomized controlled trials

Masoud, AT; Hasan, MT; Sayed, A; Edward, HN; Amer, AM; Naga, AE; Elfil, M; Alghamdi, BS; Perveen, A; Ashraf, GM; Bahbah, EI

Bahbah, EI (corresponding author), Al Azhar Univ, Fac Med, Dumyat, Egypt.; Ashraf, GM (corresponding author), King Abdulaziz Univ, Preclin Res Unit, King Fahd Med Res Ctr, Jeddah, Saudi Arabia.

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021; 427 ():

Abstract

The Global burden of disease study ranked migraine as the sixth most common disorder worldwide in 2016, with significant social and economic sequelae.......

Full Text Link